Bob Woods
This section of the web site contains media releases from January 1997 to December 1997 for Bob Woods.
Date: 3/2/1997
Title: Guidelines for genetically modified food
Description:
All foods derived from gene technology would be prohibited from sale until health and safety requirements were satisfied under a new draft food standard released for discussion today by Senator Bob Woods
Date: 24/1/1997
Title: TGA review released
Description:
Australia's medicinal product regulatory body, the Therapeutic Goods Administration (TGA), is set to streamline regulatory procedures, reinforcing its commitment to protecting public health and safety
Date: 13/1/1997
Title: Senator opens new line for the deaf and hearing impaired
Description:
People who are deaf or have a hearing or speech impediment have a new and direct line to the Federal Government through a teletypewriter (TTY) now installed in the office of Senator Bob Woods
Date: 10/1/1997
Title: Expanded role for the National HIV Reference Laboratory
Description:
Australia's National HIV Reference Laboratory (NRL) is to be expanded and developed into a centre for excellence for assessing the quality of tests used to diagnose blood borne diseases, Senator Bob Woods announced today.
Date: 10/1/1997
Title: Expanded role for the national HIV reference laboratory
Description:
Australia's National HIV Reference Laboratory (NRL) is to be expanded and developed into a centre for excellence for assessing the quality of tests used to diagnose blood borne diseases, Senator Bob Woods announced today
Date: 8/1/1997
Title: New chairman for drug evaluation committee
Description:
International clinical cancer expert, Professor Martin Tattersall, has been appointed as Chair of the Australian Drug Evaluation Committee (ADEC), Senator Bob Woods announced today.
Date: 8/1/1997
Title: New chairman for drug evaluation committee
Description:
International clinical cancer expert Professor Martin Tattersall has been appointed as Chair of Australia's peak advisory body on drug evaluation, the Australian Drug Evaluation Committee (ADEC), Senator Bob Woods announced today
